Kennedy Capital Management’s Iovance Biotherapeutics IOVA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-344,042	Closed	-$1.57M	–	697
2023 Q3	$1.57M	Buy	344,042 +118,133	+52%	+$771K	0.04%	503
2023 Q2	$1.59M	Sell	225,909 -182,567	-45%	-$1.31M	0.04%	500
2023 Q1	$2.5M	Sell	408,476 -154,659	-27%	-$1.07M	0.07%	374
2022 Q4	$3.6M	Sell	563,135 -110,491	-16%	-$863K	0.1%	336
2022 Q3	$6.45M	Buy	673,626 +9,178	+1%	+$106K	0.19%	185
2022 Q2	$7.34M	Buy	664,448 +230,990	+53%	+$3.03M	0.21%	178
2022 Q1	$7.22M	Buy	433,458 +20,758	+5%	+$321K	0.17%	218
2021 Q4	$7.88M	Sell	412,700 -11,501	-3%	-$253K	0.17%	229
2021 Q3	$10.5M	Buy	424,201 +47,282	+13%	+$1.11M	0.23%	136
2021 Q2	$9.81M	Buy	376,919 +339,486	+907%	+$8.82M	0.21%	167
2021 Q1	$1.19M	Sell	37,433 -3,759	-9%	-$156K	0.02%	541
2020 Q4	$1.91M	Sell	41,192 -397	-1%	-$15.8K	0.04%	510
2020 Q3	$1.37M	Sell	41,589 -319	-0.8%	-$9.78K	0.04%	521
2020 Q2	$1.15M	Buy	41,908 +280	+0.7%	+$9.21K	0.03%	564
2020 Q1	$1.25M	Sell	41,628 -11,037	-21%	-$293K	0.05%	529
2019 Q4	$1.46M	Sell	52,665 -461	-0.9%	-$10.5K	0.04%	586
2019 Q3	$967K	Sell	53,126 -21,525	-29%	-$476K	0.02%	595
2019 Q2	$1.83M	Buy	+74,651	New	+$1.12M	0.04%	550